Alder Biopharmaceuticals Statistics, Revenue Totals, Facts & News (2022)

Last Updated on: February 26th, 2022

Alder BioPharmaceuticals Statistics, Revenue Totals and Facts 2022


Here are a few of the most interesting Alder Biopharmaceuticals statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.


Alder Biopharmaceuticals Facts

  • Alder Biopharmaceuticals Website: Official Website
  • Year Alder Biopharmaceuticals was Founded: 2004
  • Alder Biopharmaceuticals Headquarters: Bothell, WA
  • Alder Biopharmaceuticals Founder(s): Bob Azelby
  • Alder Biopharmaceuticals Parent Company: Lundbeck

What is Alder Biopharmaceuticals?

Alder is a biopharmaceutical company committed to transforming migraine treatment through the discovery, development and commercialization of novel therapeutic antibodies. The company’s mission is to forever change migraine treatment and give people with migraine their lives back. (source)

Alder Biopharmaceuticals Employee Count

Number of Alder Biopharmaceuticals employees:

202 employees

Last updated 1/1/20


Alder Biopharmaceuticals Revenue Totals

Alder Biopharmaceuticals annual net income:


Please note that some of these numbers are easier to find than others. A few of these Alder Biopharmaceuticals statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.


Related Categories:

Categories
All Stats and Fun Facts, Biotech Statistics, Business Statistics

Related Tags:

tags
,

About Craig Smith

DMR Publisher. Director of Marketing by day and I run this little site at night. Other interests include Disney, Sports, 80's Nostalgia, LEGO, Star Wars and Tech Gadgets. Other sites include DisneyNews.us and VideoGamesStats.com.